These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2105930

  • 21. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.
    Owensby DA, Morton PA, Schwartz AL.
    J Biol Chem; 1989 Oct 25; 264(30):18180-7. PubMed ID: 2553701
    [Abstract] [Full Text] [Related]

  • 22. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
    Bikfalvi A, Sauzeau C, Moukadiri H, Maclouf J, Busso N, Bryckaert M, Plouet J, Tobelem G.
    J Cell Physiol; 1991 Oct 25; 149(1):50-9. PubMed ID: 1719003
    [Abstract] [Full Text] [Related]

  • 23. Characterization of interaction of active-site serine mutants of tissue-type plasminogen activator with plasminogen activator inhibitor-1.
    Monge JC, Lucore CL, Fry ET, Sobel BE, Billadello JJ.
    J Biol Chem; 1989 Jun 25; 264(18):10922-5. PubMed ID: 2499585
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
    Kunitada S, FitzGerald GA, Fitzgerald DJ.
    Blood; 1992 Mar 15; 79(6):1420-7. PubMed ID: 1547340
    [Abstract] [Full Text] [Related]

  • 27. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 15; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes.
    Wing LR, Bennett B, Booth NA.
    FEBS Lett; 1991 Jan 14; 278(1):95-7. PubMed ID: 1847116
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
    Cheng XF, Bäck O, Nilsson TK, Nylander Lundqvist E, Pohl G, Wallén P.
    Biochem J; 1992 Oct 15; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
    [Abstract] [Full Text] [Related]

  • 33. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
    Madison EL, Goldsmith EJ, Gerard RD, Gething MJ, Sambrook JF, Bassel-Duby RS.
    Proc Natl Acad Sci U S A; 1990 May 15; 87(9):3530-3. PubMed ID: 2110366
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Binding of recombinant variants of human tissue-type plasminogen activator (t-PA) to human umbilical vein endothelial cells.
    Stockinger H, Kubbies M, Rudolph R, Stern A, Kohnert U, Fischer S.
    Thromb Res; 1992 Sep 01; 67(5):589-99. PubMed ID: 1333104
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.